The samples were organized into Tertiles based on the OPG serum levels determined at the start of the study before patients developed breast cancer: T1 = < 0.18 ng/ml, T2 = 0.18– < 0.22 ng/ml, and T3 = ≥ 0.22 ng/ml. This evidence concerns the gene TNFRSF11B and breast cancer.